Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age7+
SponsorHacettepe University

About this trial

It is recommended to focus on the physical functionality, chewing, and swallowing performance of individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. The aim was to assess the biopsychosocial characteristics of both children and adults diagnosed with scleroderma and to examine their chewing and swallowing performance.

Additionally, this study aims to identify effective scales that can be used in future research to assess chewing and swallowing in individuals diagnosed with scleroderma.

Eligibility criteria

Qualifiers

Cases diagnosed with scleroderma,

Cases aged 7-18 years will be included.

Disqualifiers

Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies

Cases that are not willing to participate in the study will be excluded.

Having participated in a regular exercise program for the past 3 months

Individuals who are not willing to participate in the study

Trial design

Treatments tested in this trial

  • Questionnaire application for child and adult scleroderma patients

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators